248 related articles for article (PubMed ID: 15325437)
21. Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.
Dutta S; Sur D; Manna B; Sen B; Bhattacharya M; Bhattacharya SK; Wain J; Nair S; Clemens JD; Ochiai RL
Int J Antimicrob Agents; 2008 Apr; 31(4):387-9. PubMed ID: 18280709
[No Abstract] [Full Text] [Related]
22. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
Mengo DM; Kariuki S; Muigai A; Revathi G
J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.
Saha SK; Darmstadt GL; Baqui AH; Crook DW; Islam MN; Islam M; Hossain M; El Arifeen S; Santosham M; Black RE
J Clin Microbiol; 2006 Oct; 44(10):3811-3. PubMed ID: 17021117
[TBL] [Abstract][Full Text] [Related]
24. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Rodrigues C; Kumar NJ; Lalwani J; Mehta A
Indian J Med Microbiol; 2009; 27(3):276. PubMed ID: 19584518
[No Abstract] [Full Text] [Related]
25. Antibiotic resistance of Salmonella enterica serovar Paratyphi A in India: emerging and reemerging problem.
Mandal S; Mandal MD; Pal NK
J Postgrad Med; 2006; 52(3):163-6. PubMed ID: 16855314
[TBL] [Abstract][Full Text] [Related]
26. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
[TBL] [Abstract][Full Text] [Related]
27. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
Verma S; Thakur S; Kanga A; Singh G; Gupta P
Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
[TBL] [Abstract][Full Text] [Related]
28. Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012).
Singhal L; Gupta PK; Kale P; Gautam V; Ray P
Indian J Med Microbiol; 2014; 32(2):149-52. PubMed ID: 24713900
[TBL] [Abstract][Full Text] [Related]
29. Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar typhi with reduced susceptibility to ciprofloxacin.
Mandal S; Mandal MD; Pal NK
Jpn J Infect Dis; 2003 Aug; 56(4):156-7. PubMed ID: 14583638
[TBL] [Abstract][Full Text] [Related]
30. Typhoid fever due to multiresistant Salmonella enterica serovar typhi having reduced susceptibility to ciprofloxacin and nalidixic acid resistance.
Panhotra BR; Saxena AK; Al-Ghamdi AM
Saudi Med J; 2004 Oct; 25(10):1509-11. PubMed ID: 15494840
[No Abstract] [Full Text] [Related]
31. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
32. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Ciraj AM; Seema DS; Bhat GK; Shivananda PG
Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
[No Abstract] [Full Text] [Related]
33. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
34. Absence of multidrug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolates with intermediate susceptibility to ciprofloxacin.
Misra R; Prasad KN; Amrin N; Kapoor P; Singh S; Ghar M
Trans R Soc Trop Med Hyg; 2015 Aug; 109(8):538-40. PubMed ID: 25979527
[TBL] [Abstract][Full Text] [Related]
35. Trends in antibiotic susceptibility of enteric fever isolates in East London.
Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
[TBL] [Abstract][Full Text] [Related]
36. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Madhulika U; Harish BN; Parija SC
Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
[TBL] [Abstract][Full Text] [Related]
37. High level of resistance to nalidixic acid in Salmonella enterica serovar Typhi in Central India.
Kumar Y; Sharma A; Mani KR
J Infect Dev Ctries; 2009 Jul; 3(6):467-9. PubMed ID: 19762961
[TBL] [Abstract][Full Text] [Related]
38. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
39. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.
Yanagi D; de Vries GC; Rahardjo D; Alimsardjono L; Wasito EB; De I; Kinoshita S; Hayashi Y; Hotta H; Osawa R; Kawabata M; Shirakawa T
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):422-6. PubMed ID: 19631095
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
